Developing a standard approach to immune checkpoint inhibitor toxicity management in Ontario.

被引:0
作者
Crespo, Andrea
Abella, Lourdes
Baetz, Tara D.
Gallo-Hershberg, Daniela
Lakhani, Nita
Leighl, Natasha B.
Pasetka, Mark
Seymour, Lesley
Vu, Kathy
Forbes, Leta Marie
机构
[1] Canc Care Ontario, Toronto, ON, Canada
[2] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
关键词
D O I
10.1200/JCO.2018.36.30_suppl.255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
255
引用
收藏
页数:2
相关论文
共 50 条
[31]   Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities [J].
Goodman, Rachel S. ;
Jung, Seungyeon ;
Balko, Justin M. ;
Johnson, Douglas B. .
IMMUNOLOGICAL REVIEWS, 2023, 318 (01) :157-166
[32]   The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity [J].
Jain, Sidharth S. ;
Burton Sojo, Giselle ;
Sun, Harry ;
Friedland, Benjamin N. ;
Mcnamara, Megan E. ;
Schmidt, Marcel O. ;
Wellstein, Anton .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
[33]   Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines [J].
Kang, Jee Hye ;
Bluestone, Jeffrey A. ;
Young, Arabella .
TRENDS IN IMMUNOLOGY, 2021, 42 (04) :293-311
[34]   Immune checkpoint inhibitor toxicity in the clinical practice setting. [J].
Schmidt, Laura ;
McGuire, Brian ;
Hui, Wendy ;
Carro, George W. ;
Hensing, Thomas A. ;
Shevrin, Daniel H. ;
Campbell, Nicholas Paul ;
Hanson, Britt Erika ;
Brockstein, Bruce .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[35]   Acute Encephalitis and Myocarditis Due to Immune Checkpoint Inhibitor Toxicity [J].
Rahman, O. ;
Wiseman, N. ;
Shafiq, F. ;
Greenspan, A. ;
Tahir, A. ;
Saeed, R. ;
Khan, S. ;
Ahmed, D. ;
Afzal, F. ;
Khan, H. ;
Aamir, A. ;
Khan, H. ;
Sharif, A. ;
Younas, Z. ;
Alam, F. ;
Siddiqui, H. ;
Aamer, S. ;
Iqbal, M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2025, 211
[36]   Concomitant Medication Effects on Immune Checkpoint Inhibitor Efficacy and Toxicity [J].
Sieber, Brendan ;
Strauss, Julius ;
Li, Zihai ;
Gatti-Mays, Margaret E. .
FRONTIERS IN ONCOLOGY, 2022, 12
[37]   APPROACH TO MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR-INDUCED VERSUS ACUTE VIRAL MYOCARDITIS [J].
Syed, Noreen ;
Chawla, Shawn ;
Dulnuan, Kenneth .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12) :4330-4330
[38]   A Multidisciplinary Approach to Improve the Management of Immune-Checkpoint Inhibitor-Related Pneumonitis [J].
Valente, Monica ;
Colucci, Maura ;
Vegni, Virginia ;
Croce, Valentina ;
Bellan, Cristiana ;
Rossi, Giulia ;
Gibilisco, Giulia ;
Frongia, Francesco ;
Guazzo, Raffaella ;
Ghiribelli, Claudia ;
Bargagli, Elena ;
Savelli, Vinno ;
Ravara, Matteo ;
Sani, Tommaso ;
Simonetti, Elena ;
Maio, Michele ;
Calabro, Luana ;
Di Giacomo, Anna Maria .
ONCOTARGETS AND THERAPY, 2024, 17 :673-681
[39]   Toxicity management in patients treated with immune checkpoint inhibitors [J].
Rothschild, S., I .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 :147-148
[40]   Management of pulmonary toxicity associated with immune checkpoint inhibitors [J].
Delaunay, Myriam ;
Prevot, Gregoire ;
Collot, Samia ;
Guilleminault, Laurent ;
Didier, Alain ;
Mazieres, Julien .
EUROPEAN RESPIRATORY REVIEW, 2019, 28 (154)